Datadog To Rally Around 25%? Here Are 10 Top Analyst Forecasts For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst…
How To Earn $500 A Month From McKesson Stock Ahead Of Q4 Earnings Report
McKesson offers a quarterly dividend amount of 62 cents per share. How can investors pocket a regular $500 monthly?
Investor Optimism Decreases Slightly, But Dow Records Gains For 4th Day
The CNN Money Fear and Greed index showed a slight decline in the overall market sentiment, but the…
Disney, Electronic Arts And 3 Stocks To Watch Heading Into Tuesday
With U.S. stock futures trading mixed this morning on Tuesday, some of the stocks that may grab investor…
How Is The Market Feeling About McKesson?
McKesson’s (NYSE:MCK) short percent of float has fallen 10.48% since its last report. The company recently reported that…
McKinsey Faces Criminal Probe By DOJ For Opioid Consulting: Report
The U.S. Department of Justice is conducting a criminal investigation into the consulting firm McKinsey & Company for its role in advising major opioid manufacturers on increasing sales. The investigation also focuses on potential obstruction of justice related to McKinsey's consulting records for opioid producers.
Jim Cramer Is ‘Willing To Let This Pharma Stock Catch Fire,’ Advises Not To Sell McKesson
The "Mad Money" host recommended buying some Marvell Technology, and then wait until under $60 to buy the rest.
Peering Into McKesson’s Recent Short Interest
McKesson’s (NYSE:MCK) short percent of float has risen 9.17% since its last report. The company recently reported that…
Rite Aid Forges Path To Financial Recovery With Major Settlement: Report
Rite Aid (OTC: RADCQ) settles with lenders and DOJ, marking a crucial step toward bankruptcy resolution by April, Reuters reports. Attorney Aparna Yenamandra highlights broad stakeholder agreement, signaling progress despite remaining complexities. Junior bondholders, including Brigade Capital Management, express caution.
US Federal Trade Commission Investigates Drug Shortages Amid Allegations Of Market Manipulation
FTC probes chemotherapy shortages, scrutinizing drug distributors and hospital groups. Root causes of drug shortages under scrutiny. Industry defends practices.